Risk factors for infectious complications of ANCA-associated vasculitis: a cohort study. BMC Nephrology (2018) 19:138
Mesangial proliferative lupus nephritis with podocytopathy: a special entity of lupus nephritis. LUPUS,2018;27(2): 303-311
Risk factors for renal survival in Chinese patients with Myeloperoxidase-ANCA-associated GN. Clin J Am Soc Nephrol, 2017;12:417-425
Clinical-morphological features and outcomes of lupus podocytopathy. Clin J Am Soc Nephrol, 2016, 11(4):585-921
Long-term outcome of mycophenolate mofetil treatment for patients with microscopic polyangiitis: An observational study in Chinese patients. Rheumatol Int, 2016;36:967-974. DOI 10.1007/s00296-016-3492-5
Double filtration plasmapheresis in the treatment of ANCA associated vasculitis with severe renal failure: A preliminary study of 15 patients. Therapeutic Apheresis and Dialysis. 2016;20(2):183-188
Long-term outcomes in antineutrophil cytoplasmic autoantibody–positive eosinophilic granulomatosis with polyangiitis patients with renal involvement: a retrospective study of 14 Chinese patients. BMC Nephrol. 2016;17:101. DOI:10.1186/s12882-016-0319-2
Clinic-Pathological Features and Outcomes of patients with Propylthiouracil-associated ANCA vasculitis with renal involvement. J Nephrol (2014) 27:159–164 (IF 2.02)
Glucocorticoid with or without additional immunosuppressant therapy for patients with lupus podocytopathy: a retrospective single-center study. Lupus,2015, 25:1067-1075
Diffuse segmental and pure diffuse global proliferative glomerulonephritis: different patterns of class IV lupus nephritis. Clin Nephrol. 2014,81(6):411-418